OrthoPediatrics Corp is primarily active in the medical device industry, specifically focusing on orthopedic products and solutions for children.

Some of the main competitors of OrthoPediatrics Corp in the market include Zimmer Biomet Holdings Inc., Johnson & Johnson, and Stryker Corporation.

OrthoPediatrics Corp is a leading orthopedic company specializing in pediatric orthopedic medical devices and technologies. Founded in 2006, the company has established itself as a prominent player in the market, catering exclusively to the unique needs of children. OrthoPediatrics Corp focuses on developing innovative solutions that address a wide range of orthopedic conditions in pediatric patients. With an extensive product portfolio and a strong commitment to research and development, the company has continuously expanded its presence globally. OrthoPediatrics Corp's dedication to improving the lives of children through orthopedic advancements has earned it a reputable standing in the industry.

OrthoPediatrics Corp has achieved several significant milestones. Since its inception, the company has demonstrated strong growth and innovation. It became the first company to develop a comprehensive pediatric-specific surgical implant offering. OrthoPediatrics Corp has successfully introduced advanced implants and instruments specifically designed for pediatric orthopedic surgery, addressing unmet medical needs. The company has also expanded globally, establishing a presence in over 50 countries, which has further contributed to its success. OrthoPediatrics Corp continues to pioneer in pediatric orthopedics, providing specialized solutions that improve the quality of care for children with musculoskeletal conditions.

OrthoPediatrics Corp is primarily present in the United States.

OrthoPediatrics Corp represents values of innovation, integrity, and commitment to improving pediatric orthopedic care. The company's corporate philosophy revolves around providing advanced solutions to address the unique needs of children, ensuring positive outcomes and improved quality of life. OrthoPediatrics Corp's focus on research and development, collaborative partnerships, and the highest standards of patient care showcases their strong commitment to advancing pediatric orthopedics. By leveraging cutting-edge technology and expertise, OrthoPediatrics Corp strives to enhance surgical procedures, develop innovative implants and instruments, and ultimately make a significant difference in the lives of pediatric patients worldwide.

Analysts currently set an average price target of 24,48 USD for the OrthoPediatrics stock (median: 23,46 USD), implying −2,3 % versus the latest price. The consensus is based on 15 analyst ratings.

OrthoPediatrics Analyytikkojen kursstavoitteet 2026

15 analysts currently rate the OrthoPediatrics stock: 13 recommend buying, 2 holding and 0 selling. For 2026, analysts expect OrthoPediatrics to generate revenue of 266,98 M USD and earnings per share of −1,18 USD.

OrthoPediatrics Analyytikkojen kursstavoitteet 2026

Converted at the current exchange rate, the OrthoPediatrics share trades at 21,42 EUR (24,80 USD).

The OrthoPediatrics share (KIDS) is listed on 2 stock exchanges, including: NASDAQ (KIDS), Frankfurt (2X7.F).

OrthoPediatrics Corp is a global provider of orthopedic implants and instruments for the pediatric market. The company was founded in 2006 and is headquartered in the USA. Its goal is to support children and adolescents with orthopedic conditions and enable them to lead active lives. The company has three different business areas: Products, Operative Services, and Education Services. In the Products area, OrthoPediatrics Corp offers a wide range of implants and instruments specifically designed for the treatment of children and adolescents. They offer over 30 surgical systems that can be used for a variety of diagnoses such as scoliosis, hip dysplasia, or fractures. A significant product that OrthoPediatrics Corp offers is the Pediatric Nailing System, a central technology used to manufacture many of their surgical systems. This system is specifically designed for the needs of children and adolescents and facilitates quick and accurate treatment for surgeons. Operative Services is the second business area of OrthoPediatrics Corp. Here, the company offers a variety of service options tailored to the needs of children and adolescents. This includes support for surgery planning, delivery of instruments and implants to the operating site, and providing training for medical personnel. The third business area of OrthoPediatrics Corp is education. The company offers a variety of training programs to educate doctors and medical personnel on the latest technologies and treatment methods for children and adolescents. OrthoPediatrics Corp aims to train doctors and medical personnel on handling children and adolescents through workshops, seminars, and training sessions for doctors, nurses, and other medical staff. OrthoPediatrics Corp's business model is based on the belief that there are no simple operations for children and adolescents. Therefore, the company has developed products and services that consider the specific needs of children and adolescents. The company pursues a strong brand strategy in the pediatric orthopedics market and has established a strong presence in this field. OrthoPediatrics Corp aims to further expand its market position and plans to focus strongly on international markets in the coming years. The company works closely with medical facilities, surgeons, and hospitals to provide advanced technology, excellent service, and training. OrthoPediatrics Corp will continue to be a strong partner for healthcare in the future to ensure that children and adolescents receive the best possible treatment outcomes.

odotettu liikevaihto OrthoPediatrics on 266,98 M USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.

odotettu voitto OrthoPediatrics on −27,84 M USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.

OrthoPediatrics:n hinta-voitto-suhde (P/E) on tällä hetkellä −21,00. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan OrthoPediatrics-osakkeen arvostusta.

OrthoPediatrics:n hinta-myynti-suhde (P/S) on tällä hetkellä 2,19. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii OrthoPediatrics-osakkeen arvostuskennuslukuna.

OrthoPediatrics:n Eulpool-laatuscore on 4/10.

OrthoPediatrics:n ISIN on US68752L1008. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.

OrthoPediatrics:n WKN on A2JAAV. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.

OrthoPediatrics:n ticker on KIDS. Tämä pörssinoteeraus käytetään OrthoPediatrics-osakkeiden kauppaan pörssissä.

OrthoPediatrics maksoi osinkoa joka vuosi viimeisten 0 vuoden aikana.

OrthoPediatrics kuuluu sektoriin 'Terveydenhuolto'.

OrthoPediatrics:n osingot jaetaan valuutassa USD.